Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 369

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 369
---
consultants and others use intellectual property owned by others in their work for us, we may be subject to allegations of infringement
and further disputes may arise as to the rights in related or resulting improvements, know-how and inventions.

Our success also
depends in part on not infringing the intellectual property rights of third parties. It is uncertain whether the issuance of any third-party
patent would require us to alter our development or commercial strategies, or our product candidates or processes, obtain licenses or
cease certain activities. Our breach of any license agreements or failure to obtain a license to intellectual property rights that we
may require to develop or commercialize our future product candidates may have an adverse impact on the business. If third parties have
prepared and filed patent applications in the United States prior to March 16, 2013 (the date when U.S. patent law changed from granting
rights to the first-to-invent to the first-to-file) that also claim technology to which we have rights, we may have to participate in
interference proceedings in the USPTO to determine priority of invention. Assuming that other requirements for patentability are met,
prior to March 2013, in the United States, the first to invent the claimed invention was entitled to the patent, while outside the United
States, the first to file a patent application was entitled to the patent. After March 2013, under the America Invents Act, enacted in
September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability
are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third
party was the first to invent the claimed invention. For more information regarding the risks related to our intellectual property, please
see the section titled “Risk Factors — Risks Related to Our Intellectual Property.”

| 196 |

We currently
own or have exclusive license to 18 granted patents, of which 8 are issued U.S. patents and 9 are issued outside of the United States.
We additionally own or exclusively license a number of pending patent applications related to our technology and products.

Our issued patents
expire between April 2028 and November 2037. Despite the near-term expiration of certain of our material patents, we believe that our
other patents, as well as our trade secrets and continuing technological know-how, provide us with sufficient intellectual property protection
to develop our product candidates and protect our intellectual property